Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

HCC: Updates in Management

Stanford Medicine

R. Dhanasekaran

GI Oncology Year in Review: Hepatobiliary Cancers

Yale Cancer Center

P. Kunz

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

Arndt Vogel

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

The Role of Adjuvant Therapy Following HCC Resection

Integrity CE

M. Baretti

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC

2024 ESMO Annual Meeting Insights Hub

S. L. Chan

ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of …

Insights from 2024 ESMO GI Annual Meeting

S. L. Chan

Hepatic Arterial Infusion for Primary Liver Cancer

Integrity CE

K. Lafaro